🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
An investigation of the efficacy and safety of up to 70 weeks of treatment ...
Status
Terminated
Location
Spruce Study Site
Start Date
2020-08-26
Trial ID
NCT04457336
Treatments Being Tested
An investigation of the safety and efficacy of tildacerfont in women with P...
Status
Terminated
Location
Spruce Study Site
Start Date
2022-05-15
Trial ID
NCT05370521
Treatments Being Tested
This is a multicenter Phase 2, multiple dose, dose escalation study to eval...
Status
Completed
Location
Spruce Biosciences Clinical Site
Start Date
2017-07-12
Trial ID
NCT03257462
Treatments Being Tested
An investigation of the safety and efficacy of tildacerfont in participants...
Status
Terminated
Location
Spruce Study Site
Start Date
2021-12-10
Trial ID
NCT05128942
Treatments Being Tested
This is a Phase 2 study of SPR001 for the treatment of classic CAH that wil...
Status
Completed
Location
Spruce Biosciences Clinical Site
Start Date
2018-09-06
Trial ID
NCT03687242
Treatments Being Tested
An investigation of the ability of Tildacerfont to reduce supraphysiologic ...
Status
Terminated
Location
Spruce Study Site
Start Date
2021-02-22
Trial ID
NCT04544410
Treatments Being Tested